U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H22N2OS
Molecular Weight 314.445
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METHOPROMAZINE

SMILES

COC1=CC2=C(SC3=C(C=CC=C3)N2CCCN(C)C)C=C1

InChI

InChIKey=BRABPYPSZVCCLR-UHFFFAOYSA-N
InChI=1S/C18H22N2OS/c1-19(2)11-6-12-20-15-7-4-5-8-17(15)22-18-10-9-14(21-3)13-16(18)20/h4-5,7-10,13H,6,11-12H2,1-3H3

HIDE SMILES / InChI
Methopromazine was developed as a neuroleptic agent with antipsychotic activity. Information about the current use of this compound is not available.

Approval Year

Doses

Doses

DosePopulationAdverse events​
1200 mg 1 times / day multiple, oral
Studied dose
Dose: 1200 mg, 1 times / day
Route: oral
Route: multiple
Dose: 1200 mg, 1 times / day
Sources:
unhealthy, 20-50 years
Health Status: unhealthy
Age Group: 20-50 years
Sex: F
Sources:
PubMed

PubMed

TitleDatePubMed
Application of methopromazine for the extractive spectrophotometric determination of platinum.
1983-07
[Methopromazine and adrenalin vasodilatation].
1961
[Pharmacological study of a new derivative of phenothiazine, 4632 RP or methopromazine].
1957
[Pharmacodynamic properties of methopromazine, new neuroleptic related to chlorpromazine].
1957
Name Type Language
METHOPROMAZINE
INN   WHO-DD  
INN  
Official Name English
METHOXYPROMAZINE
MI  
Preferred Name English
10-(3-DIMETHYLAMINOPROPYL)-2-METHOXYPHENOTHIAZINE
Systematic Name English
METHOXYPROMAZINE [MI]
Common Name English
methopromazine [INN]
Common Name English
Methopromazine [WHO-DD]
Common Name English
Code System Code Type Description
PUBCHEM
18847
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
INN
592
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
SMS_ID
100000081454
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
ChEMBL
CHEMBL2110655
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
MERCK INDEX
m825
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY Merck Index
FDA UNII
A6F645Q9HQ
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
EVMPD
SUB08854MIG
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
MESH
C008393
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
DRUG CENTRAL
1756
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
EPA CompTox
DTXSID90209843
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
NCI_THESAURUS
C174606
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
CAS
61-01-8
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-497-6
Created by admin on Mon Mar 31 19:17:54 GMT 2025 , Edited by admin on Mon Mar 31 19:17:54 GMT 2025
PRIMARY